Agree egg, after the fall comes the news leading to a rise. After a good rise comes the fall to accommodate others. I,ll continue here at least until a present in the form of RNS comes out way prior to Xmas. But i,ll always retain some in my SIPP for the biggie!. Good health people. :o).
Yes they'll control it but within technical boundaries mate as they always do - it's yet to break 60p and it may never do it and that stall today at 60p may underline where the big money is looking to catch sells from the impatient - as per, time will tell ...
I can't comment on the valuation stuff but I've not got any wobbles here re the SP movements - terrific stop @ 60p dead today which of course doesn't mean it can never go there but the option was there and it wasn't taken ...
I "broke it" @ 61p with not the biggest buy in the world so perhaps that means that, for the time being at least, <60p isn't on the cards and the MA20 that just flew past us and which is heading for upper 60s right now will apply some suction to the SP whilst the MA50 catches us up in the next few weeks - that MA50 hit is the real acid test and I'd expect her to do very well whenever and wherever that is seen ...
I hope potential investors - peeps and big pharmas - get to read your summary of this afternoon. It does paint such a positive,rosy picture that,yet again,I'm amazed that the SP has dipped again. I ain't going nowhere....this is one to hold on to ,and so I shall. Good weekend,everyone,OJB
Goldust. - Perhaps a few guesses as to when deals will be done would be in order, to better evaluate sp short term. We are all expecting the sp to pass 1 pound per share in short order when news arrives and particularly after income is flowing. Shall we say December for this milestone?
Alternatively one pound per share might be exceeded after the next broker update, surely due in October.
By the time the sp has tripled, you won't be that concerned what you paid, just where the next milestone is. The problem appears to be the order of arrival of good news stories and their effect on the sp. Taken individually, sp will rise for each story, but if there are two or three RNS's in a week, then a snowball effect might occur. So - short term - buy while sp is low and MM's are making it easier to get more bang for your buck.
Have done my own calculations on Futura's probable value which is as follows:- Currently Futura is very excited about their products and you can understand why. Futura has 4 products now on the launch pad CSD 500 -THE CONDOM WITH AN ERECTION ENHANCING GEL This has been licencesed across a lot of the globe and the roll out of the condom will start in the next quarter and gather pace then on. MED 2002-EROXON TREATMENT FOR ERCTILE DYSFUNCTIO Already available in the UK on prescription as a “special”-recent trials has shown this to be very effective for treatment of erectile dysfunction in men and a better treatment than Viagra with virtually zero side effects whereas Viagra and similar treatments have serious side effects.This is a gamechanger product and will likely be available as an over the counter product whereas all others are by prescription due to side effects. Futura is seeking to licence the product to a major pharma company (or companies) it currently has very significant interest to licence out and expects to do so in the coming period. TPR 100 & TIB 200-PAIN RELIEF GELS Both products tested and found to be more effective in treating pain than any current treatment such as Voltarol, Deep Heat, Bungay, Pennsaid etc This will enable it to be marketed as better than all these products. It hass had very significant interest in the product and is currently in discussions to licence out world wide with first licence nearing conclusion and could be announced next month. If you look at past info provided by Futura they have analyised the markets for all their products, have targeted for them and know their potential. So there we have it not one but 3 worldbeating products ready to go. Whats that worth-my guess after rechecking my prior assessment, based upon previous licencing fees and royalyties on similar products. CSD 500-will be royalties on sales Royalties rising to £15 + million pa MED 2002-Licence fees and royalties thereafter. Licence fees £80 million plus royalties rising to £ 30 million pa TPR100 &TIB200-Licence fees and royalties thereafter. Licence fees £ 60 million plus royalties rising to £ 20 million pa Total upfront licencing £ 140 million fees Plus Total royalties rising to £65 million per annum LICENCING FEES COULD BRING IN mre than 2 TIMES CURRENT MARKET VALUE ALONE. Current value of Futura at 62p is £ 62 million-does this make sense ? Comments anyone - please advise.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.